Description
Glutaminase C-IN-1 (Compound 968) is an allosteric inhibitor of Glutaminase C that inhibits cancer cell growth without affecting their normal cellular counterpartsIn VitroGlutaminase C-IN-1 (Compound 968) (10 µM; 14 d) inhibits cellular transformation in NIH 3T3 cells. ?\nGlutaminase C-IN-1 (10 µM; 6 d) blocks the signaling activity of a specific target of Dbl. ?\nGlutaminase C-IN-1 blocks the transforming activity of human breast cancer cells. ?\nGlutaminase C-IN-1 (10 µM) blocks glutaminolysis in transformed cells. ?\nGlutaminase C-IN-1 preferentially binds to the monomeric state of Glutaminase C. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: MDA-MB231 cells, SKBR3 cells, and NIH 3T3 cells Concentration: 10 µM Incubation Time: 5 h Result: Inhibited cell growth.In VivoGlutaminase C-IN-1 (Compound 968) (200 µg/mouse; i.p.; daily for 12 days) reduces tumor volume in mice. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: SCID mice with P493 B lymphoma cells Dosage: 200 µg/mouse Administration: Intraperitoneal injection, daily for 12 days Result: Caused a ~50% reduction in the size of the tumors.IC50& Target:Glutaminase C